J Sanderson, M.D.
NPI 1841290178 · Cardiovascular Disease Physician · Kerrville, TX
Provider details
- NPI number
- 1841290178
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- E0139 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
523 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 249 | $122 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report93000 | 64 | $14 |
| Ultrasound of Heart With Color-Depicted Blood Flow, Rate, Direction and Valve Function93306 | 49 | $184 |
| Ultrasound of Both Sides of Head and Neck Blood Flow93880 | 43 | $177 |
| Exercise Or Drug-Induced Heart Stress Test With Electrocardiogram (ecg) With Review By Physician93018 | 35 | $13 |
| Nuclear Medicine Studies of Blood Flow in Heart Muscle at Rest and With Stress |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 30 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Metoprolol Succinate | 104 | 44 |
| Valsartan | 101 | 44 |
| Lisinopril | 98 | 38 |
| Atorvastatin Calcium | 68 | 25 |
| Rosuvastatin Calcium | 66 | 32 |
| Rivaroxabanbrand: Xarelto | 57 | 18 |
| Furosemide | 57 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$209 across 9 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-28
- Last updated
- 2022-01-18
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.